In view of these compelling findings, of our previous description of the antitumor potential of G9a targeting in CCA [30], and our present observation of a direct correlation between G9a and PHGDH expression in iCCAs, we explored the crosstalk between KRAS and this HMT in CCA cells. This evidence concerns the gene EHMT2 and cholangiocarcinoma.